AVR Company Profile and Key Details
NASDAQ : AVR
Anteris Technologies Global
$4.55
-0.29-5.99%
At Close 4:00 PMPrice Chart
Stock Price Today
Anteris Technologies Global Corp. (AVR) stock declined over -5.99%, trading at $4.55 on NASDAQ, down from the previous close of $4.84. The stock opened at $4.75, fluctuating between $4.54 and $4.93 in the recent session.
Stock Snapshot
4.84
Prev. Close
149.73M
Market Cap
4.54
Day Low
-1.75
P/E Ratio
-2.6
EPS (TTM)
N/A
Cash Flow per Share
4.75
Open
32.91M
Number of Shares
4.9255
Day High
84.19%
Free Float in %
N/A
Book Value
219.31K
Volume
Relevant Articles
SEC Fillings
Current Report (8-k)
| Filing Date | Accepted Date | |
|---|---|---|
Annual Report (10-k)
| Filing Date | Accepted Date | |
|---|---|---|
Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jan 09, 2026 | 4.75 | 4.93 | 4.54 | 4.55 | 195.33K |
| Jan 08, 2026 | 4.95 | 4.96 | 4.78 | 4.84 | 131.03K |
| Jan 07, 2026 | 5.06 | 5.10 | 4.81 | 4.95 | 211.15K |
| Jan 06, 2026 | 4.97 | 5.07 | 4.70 | 4.96 | 144.06K |
| Jan 05, 2026 | 4.97 | 5.15 | 4.76 | 4.78 | 214.5K |
| Jan 02, 2026 | 5.12 | 5.28 | 4.66 | 4.92 | 133.83K |
| Dec 31, 2025 | 5.09 | 5.34 | 4.94 | 4.99 | 175.47K |
| Dec 30, 2025 | 5.28 | 5.43 | 5.04 | 5.08 | 119.81K |
| Dec 29, 2025 | 5.61 | 5.74 | 5.18 | 5.25 | 211.45K |
| Dec 26, 2025 | 5.45 | 5.90 | 5.43 | 5.59 | 191.45K |
| Dec 24, 2025 | 5.32 | 5.48 | 5.14 | 5.41 | 85.34K |
| Dec 23, 2025 | 5.36 | 5.45 | 5.05 | 5.29 | 176.68K |
| Dec 22, 2025 | 5.05 | 5.33 | 4.91 | 5.32 | 169.96K |
| Dec 19, 2025 | 5.50 | 5.50 | 4.90 | 4.94 | 610.84K |
| Dec 17, 2025 | 4.97 | 5.11 | 4.70 | 4.74 | 104.07K |
| Dec 16, 2025 | 4.70 | 5.11 | 4.68 | 4.95 | 360.26K |
| Dec 15, 2025 | 4.99 | 5.07 | 4.53 | 4.73 | 113.41K |
| Dec 12, 2025 | 5.25 | 5.29 | 4.90 | 4.98 | 169.18K |
| Dec 11, 2025 | 5.36 | 5.50 | 5.22 | 5.25 | 208.19K |
| Dec 10, 2025 | 4.73 | 5.38 | 4.73 | 5.33 | 230.96K |
Contact Details
About Company
Anteris Technologies Global Corp., a structural heart company, discovers, develops, and commercializes medical devices to enhance the quality of life for patients with aortic stenosis. Its lead product candidate is the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also devlops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. was incorporated in 1999 and is based in Toowong, Australia.
Company Information
| Employees | 136 |
| Beta | 0.48 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | -0.918% |
| Fiscal Year Ends | N/A |
| Sector | Healthcare |
| Industry | Medical - Devices |
Stock Peers
BRKRP
1.08+0.27%
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A$401.55SWAV-0.08-0.02%
ShockWave Medical, Inc.$334.75PODD-3.85-1.31%
Insulet Corporation$289.04UFPT2.09+0.82%
UFP Technologies, Inc.$257.51IRTC-9.82-5.19%
iRhythm Technologies, Inc.$179.43ALGN2.21+1.30%
Align Technology, Inc.$172.79TMDX-0.5-0.36%
TransMedics Group, Inc.$137.07IRMD-1.05-1.05%
IRadimed Corporation$98.95NARI00
Inari Medical, Inc.$79.97AXNX-
Axonics, Inc.$70.98Company Overview
Anteris Technologies Global Corp. (NASDAQ:AVR) closed at $4.55 USD, losing -$0.29 (-5.99%) from the previous close of $4.84. The stock is currently mid-range between its 52-week high and low $2.34 and $8.79. With a market capitalization of about $149.73 million, Anteris Technologies Global Corp. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.48). Key stats such as the average daily volume over the past year has been around 236.55 thousand shares, in line with its 52-week average. Headquartered in Toowong, QLD, Anteris Technologies Global Corp. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Wayne Geoffrey Paterson, the company employs approximately 136 people and listed since December 13, 2024. Anteris Technologies Global Corp., a structural heart company, discovers, develops, and commercializes medical devices to enhance the quality of life for patients with aortic stenosis.
Technical Performance
Short-term trend indicators are bearishly aligned (SMA20 -9.89%, SMA50 1.52%, SMA200 8.1%). The stock’s 14-day RSI is 43.94 (neutral), while the ATR of 0.41 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -48.24% below its high and over 94.44% above its low. Average 10-day trading volume of 171.65 thousand shares is in line with the 3-month average of 175.63 thousand, indicating normal recent market interest.
Dividend & Fair Value
Anteris Technologies Global Corp. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $1.04. This means the shares are trading above this model’s fair value.
Earnings & Analyst Outlook
Wall Street analysts project EPS growth of 27.66% annually over the next five years. Anteris Technologies Global Corp. earnings surprise history is a mixed track record. The quarter that ended November 12, 2025, missed forecasts by 3.33%. The prior quarter beat by 16.0%. Over the last six quarters, Apple has recorded several small beats. These include 35.56% in May 13, 2025.
Shareholding & Insider Activity
Anteris Technologies Global Corp. has 41.20 million shares outstanding. The public float is 38.10 million shares, elevated short interest at 4.76% of float. This equals 1.64 million shares. The short ratio is 12.51 days. Institutional investors hold 61.4% of the float. Insiders own 0.43%.
Frequently Asked Questions
What is the current Anteris Technologies Global Corp. (AVR) stock price?
Anteris Technologies Global Corp. (NASDAQ: AVR) stock price is $4.55 in the last trading session. During the trading session, AVR stock reached the peak price of $4.93 while $4.54 was the lowest point it dropped to. The percentage change in AVR stock occurred in the recent session was -5.99% while the dollar amount for the price change in AVR stock was - $0.29.
AVR's industry and sector of operation?
The NASDAQ listed AVR is part of Medical - Devices industry that operates in the broader Healthcare sector. Anteris Technologies Global Corp. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of AVR?
No Data
How AVR did perform over past 52-week?
AVR's closing price is 94.44% higher than its 52-week low of $2.34 where as its distance from 52-week high of $8.79 is -48.24%.
How many employees does AVR have?
Number of AVR employees currently stands at 136.
Link for AVR official website?
Official Website of AVR is: https://anteristech.com
How do I contact AVR?
AVR could be contacted at phone 611 300 550310 and can also be accessed through its website. AVR operates from Toowong Tower, Toowong, QLD 4066, Australia.
How many shares of AVR are traded daily?
AVR stock volume for the day was 219.31K shares. The average number of AVR shares traded daily for last 3 months was 236.55K.
What is the market cap of AVR currently?
The market value of AVR currently stands at $149.73M with its latest stock price at $4.55 and 32.91M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep